|
|
 |
PREZCOBIX Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POVIDONE K90 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POTASSIUM METABISULFITE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
PRIALT Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POVIDONE K30 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|